Mercy Medical Oncologist Dr. David Riseberg Discusses COVID-19 and its Impact on Cancer Patients

People undergoing cancer treatments have immunosuppressed systems, making it harder to fight off infections, like the coronavirus. That puts them at a higher risk for serious complications, like pneumonia and hospitalization.

Oncologists are taking a closer look at continuing or modifying cancer treatments for patients.

According to Dr. David Riseberg, Chief of Medical Oncology and Hematology at Mercy Medical Center, continuing treatment depends upon the circumstance. For many patients, treatment is continued if it's important for their health in relation to the cancer.

“There are some situations though, where maybe the indication for chemotherapy is such where it's okay to delay it for a little bit. So, particularly in breast cancer, we have the opportunity sometimes to use pills that are estrogen-blocking. We can do that for a few months then go back to chemo. So we're really taking it on a case-by-case basis,” Dr. Riseberg said.

If you are undergoing treatment, it's advised you call your health care provider before your next appointment and follow their guidance.

As health care systems adjust their activities to address the virus, doctors treating cancer patients may also have to change when and how cancer treatment and follow-up visits are carried out.

The risk of missing a cancer treatment or medical appointment must be weighed against the possibility of exposing a patient to infection.

To view Mercy medical oncologist Dr. David Riseberg’s interview about chemotherapy patients and COVID-19, click here.